📊 ACOG Key Takeaways
Is Alpha Cognition Inc. (ACOG) a Good Investment?
Alpha Cognition is a pre-revenue stage biotech company with severe unprofitability, negative cash flows, and no clear path to profitability. Despite holding $35.4M in cash, the company is burning capital rapidly at -$13.6M free cash flow annually, with operating losses of -$14.7M against only $7.4M in revenue. The fundamental financials show an unsustainable business model with deteriorating margins and mounting losses.
Alpha Cognition's fundamentals show a company with limited scale relative to its cost base, producing deeply negative operating and net margins despite reporting revenue. The balance sheet is currently strong, with substantial cash, no meaningful leverage, and high liquidity, but the business is still consuming cash and has not demonstrated durable operating leverage or high-quality growth.
Why Buy Alpha Cognition Inc. Stock? ACOG Key Strengths
- Strong cash position of $35.4M provides 2.6 years of runway at current burn rate
- Excellent liquidity with current ratio of 6.69x and minimal debt
- Recent EPS improvement of 47.4% YoY suggests potential share dilution reduction or loss mitigation
- Strong liquidity position with $35.40M in cash and a 6.69x current ratio
- Debt-free capital structure reduces financial risk and preserves flexibility
- Cash burn is meaningful but manageable in the near term relative to current cash reserves
ACOG Stock Risks: Alpha Cognition Inc. Investment Risks
- Operating losses of -$14.7M exceed revenue by 198%, indicating business model is not viable at current scale
- Negative free cash flow of -$13.6M annually will deplete cash reserves without significant revenue growth or profitability inflection
- Net margin of -186% and ROE of -40.7% demonstrate severe value destruction and inability to generate returns on shareholder capital
- High insider activity (15 Form 4 filings in 90 days) may indicate management uncertainty or equity compensation dilution
- Extremely weak profitability, including -198.4% operating margin and -186.0% net margin
- Negative operating cash flow and free cash flow indicate the business is not self-funding
- Revenue quality and scalability remain uncertain given losses far exceed current revenue base
Key Metrics to Watch
- Quarterly revenue growth rate and path to positive gross margins
- Monthly cash burn rate and runway extension timeline
- Operating margin improvement trajectory toward breakeven
- Clinical trial progress or product pipeline advancement milestones
- Insider transaction patterns and their impact on share dilution
- Quarterly revenue growth versus operating expense growth
- Operating cash burn and remaining cash runway
Alpha Cognition Inc. (ACOG) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 6.69x current ratio provides a solid financial cushion.
ACOG Profit Margin, ROE & Profitability Analysis
ACOG vs Healthcare Sector: How Alpha Cognition Inc. Compares
How Alpha Cognition Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Alpha Cognition Inc. Stock Overvalued? ACOG Valuation Analysis 2026
Based on fundamental analysis, Alpha Cognition Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Alpha Cognition Inc. Balance Sheet: ACOG Debt, Cash & Liquidity
ACOG Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Alpha Cognition Inc.'s revenue has declined by 90% over the 5-year period, indicating business contraction. The most recent EPS of $-2.04 indicates the company is currently unprofitable.
ACOG Revenue Growth, EPS Growth & YoY Performance
ACOG Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $2.8M | -$1.3M | $-0.30 |
| Q2 2025 | $1.7M | -$2.1M | $-0.35 |
| Q1 2025 | $2.9M | -$2.0M | $-0.13 |
| Q3 2024 | $100.0M | -$1.9M | $-0.31 |
| Q2 2024 | $100.0M | -$2.1M | $-0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Alpha Cognition Inc. Dividends, Buybacks & Capital Allocation
ACOG SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Alpha Cognition Inc. (CIK: 0001655923)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ACOG
What is the AI rating for ACOG?
Alpha Cognition Inc. (ACOG) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 87% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ACOG's key strengths?
Claude: Strong cash position of $35.4M provides 2.6 years of runway at current burn rate. Excellent liquidity with current ratio of 6.69x and minimal debt. ChatGPT: Strong liquidity position with $35.40M in cash and a 6.69x current ratio. Debt-free capital structure reduces financial risk and preserves flexibility.
What are the risks of investing in ACOG?
Claude: Operating losses of -$14.7M exceed revenue by 198%, indicating business model is not viable at current scale. Negative free cash flow of -$13.6M annually will deplete cash reserves without significant revenue growth or profitability inflection. ChatGPT: Extremely weak profitability, including -198.4% operating margin and -186.0% net margin. Negative operating cash flow and free cash flow indicate the business is not self-funding.
What is ACOG's revenue and growth?
Alpha Cognition Inc. reported revenue of $7.4M.
Does ACOG pay dividends?
Alpha Cognition Inc. does not currently pay dividends.
Where can I find ACOG SEC filings?
Official SEC filings for Alpha Cognition Inc. (CIK: 0001655923) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ACOG's EPS?
Alpha Cognition Inc. has a diluted EPS of $-0.87.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ACOG a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Alpha Cognition Inc. has a SELL rating with 87% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ACOG stock overvalued or undervalued?
Valuation metrics for ACOG: ROE of -40.7% (sector avg: 15%), net margin of -186.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ACOG stock in 2026?
Our dual AI analysis gives Alpha Cognition Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ACOG's free cash flow?
Alpha Cognition Inc.'s operating cash flow is $-13.5M, with capital expenditures of $146.0K. FCF margin is -183.4%.
How does ACOG compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -186.0% (avg: 12%), ROE -40.7% (avg: 15%), current ratio 6.69 (avg: 2).